SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $86.52 | 52-week high | $105.47 |
| Prev. close | $85.87 | 52-week low | $66.66 |
| Day low | $85.50 | Volume | 5,054,244 |
| Day high | $86.63 | Avg. volume | 10,667,808 |
| 50-day MA | $82.81 | Dividend yield | 0.04% |
| 200-day MA | $0.00 |
XBI Stock Price Chart Interactive Chart >
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
| Issuer | State Street Investment Management |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Biotechnology Select Industry Index |
| Asset Class | Equity |
| Sector | Biotech |
| Assets Under Management (AUM) | 4.77M |
| Net Asset Value (NAV) | $88.08 |
| Options? | Yes |
| Total Holdings | 129 |
XBI Top Holdings
| Symbol | Company | % of Total |
| MRNA | MODERNA INC | 2.72% |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 2.6% |
| EXEL | EXELIXIS INC | 2.6% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 2.57% |
| UTHR | UNITED THERAPEUTICS CORP | 2.55% |
| HALO | HALOZYME THERAPEUTICS INC | 2.53% |
| INSM | INSMED INC | 2.53% |
| REGN | REGENERON PHARMACEUTICALS | 2.53% |
| VRTX | VERTEX PHARMACEUTICALS INC | 2.46% |
| AMGN | AMGEN INC | 2.44% |
XBI Price Returns
| 1-mo | 5.03% |
| 3-mo | 9.39% |
| 6-mo | -6.93% |
| 1-year | -12.48% |
| 3-year | 7.43% |
| 5-year | -24.41% |
| YTD | -3.92% |
| 2024 | 1.01% |
| 2023 | 7.60% |
| 2022 | -25.87% |
| 2021 | -20.45% |
| 2020 | 48.33% |
XBI Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||